🇺🇸 PB 6 doses - Rifampicin, Clofazimine and Dapsone in United States

PB 6 doses - Rifampicin, Clofazimine and Dapsone (PB 6 doses - Rifampicin, Clofazimine and Dapsone) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

PB 6 doses - Rifampicin, Clofazimine and Dapsone in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is PB 6 doses - Rifampicin, Clofazimine and Dapsone approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for PB 6 doses - Rifampicin, Clofazimine and Dapsone in United States?

University of Brasilia is the originator. The local marketing authorisation holder may differ — check the official source linked above.